Now showing items 1-1 of 1

    • The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant. 

      Lakeman, IMM; van den Broek, AJ; Vos, JAM; Barnes, DR; Adlard, J; Andrulis, IL; Arason, A; Arnold, N; Arun, BK; Balmaña, J; Barrowdale, D; Benitez, J; Borg, A; Caldés, T; Caligo, MA; Chung, WK; Claes, KBM; GEMO Study Collaborators; EMBRACE Collaborators; Collée, JM; Couch, FJ; Daly, MB; Dennis, J; Dhawan, M; Domchek, SM; Eeles, R; Engel, C; Evans, DG; Feliubadaló, L; Foretova, L; Friedman, E; Frost, D; Ganz, PA; Garber, J; Gayther, SA; Gerdes, A-M; Godwin, AK; Goldgar, DE; Hahnen, E; Hake, CR; Hamann, U; Hogervorst, FBL; Hooning, MJ; Hopper, JL; Hulick, PJ; Imyanitov, EN; OCGN Investigators; HEBON Investigators; KconFab Investigators; Isaacs, C; Izatt, L; Jakubowska, A; James, PA; Janavicius, R; Jensen, UB; Jiao, Y; John, EM; Joseph, V; Karlan, BY; Kets, CM; Konstantopoulou, I; Kwong, A; Legrand, C; Leslie, G; Lesueur, F; Loud, JT; Lubiński, J; Manoukian, S; McGuffog, L; Miller, A; Gomes, DM; Montagna, M; Mouret-Fourme, E; Nathanson, KL; Neuhausen, SL; Nevanlinna, H; Yie, JNY; Olah, E; Olopade, OI; Park, SK; Parsons, MT; Peterlongo, P; Piedmonte, M; Radice, P; Rantala, J; Rennert, G; Risch, HA; Schmutzler, RK; Sharma, P; Simard, J; Singer, CF; Stadler, Z; Stoppa-Lyonnet, D; Sutter, C; Tan, YY; Teixeira, MR; Teo, SH; Teulé, A; Thomassen, M; Thull, DL; Tischkowitz, M; Toland, AE; Tung, N; van Rensburg, EJ; Vega, A; Wappenschmidt, B; Devilee, P; van Asperen, CJ; Bernstein, JL; Offit, K; Easton, DF; Rookus, MA; Chenevix-Trench, G; Antoniou, AC; Robson, M; Schmidt, MK (2021-06-10)
      Purpose To evaluate the association between a previously published 313 variant-based breast cancer (BC) polygenic risk score (PRS<sub>313</sub>) and contralateral breast cancer (CBC) risk, in BRCA1 and BRCA2 pathogenic ...